NYSE CRTR Economy Event Watch the replay →

Advertisement
Advertisement

XPHvsXLVETF Comparison

ETF 1
XPH

State Street SPDR S&P Pharmaceuticals ETF

This fund is part of
US Health Care
+1.15%
VS
ETF 2
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
+1.15%

State Street SPDR S&P Pharmaceuticals ETF (XPH) and State Street Health Care Select Sector SPDR ETF (XLV) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. XPH is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.08% for XLV. XPH is up 6.83% year-to-date (YTD) with +$110M in YTD flows. XLV performs worse with -0.05% YTD performance, and -$91M in YTD flows. Run a side-by-side ETF comparison of XPH and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XPH vs XLV performance and flow charts

Performance

-4.0-2.00.02.04.06.08.0%May 11May 18May 26Jun 2Jun 9

Cumulative Flows

-1 B-0.8 B-0.6 B-0.4 B-0.2 B0 B0.2 BMay 11May 18May 26Jun 2Jun 9

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 06/11/2026
1M3MYTD1Y3Y5Y
Perf.
XPH
XLV
+2.68%+7.73%
+8.04%+1.18%
+6.83%-0.05%
+43.48%+15.53%
+52.11%+23.75%
+20.56%+34.09%
Flows
XPH
XLV
-$8M-$533M
+$17M-$1.10B
+$110M-$91M
+$133M+$33M
+$51M-$7.23B
+$63M+$4.82B
Volatility and drawdown
3M1Y3Y5Y
Volatility
XPH
XLV
+25.99%+16.37%
+21.47%+15.02%
+19.90%+13.97%
+20.72%+14.72%
Max drawdown
XPH
XLV
-8.13%-6.22%
-11.78%-10.51%
-23.45%-17.05%
-31.59%-17.05%
Max drawdown duration
XPH
XLV
36d85d
50d102d
322d444d
1566d444d
Trading data

Create an account to view trading data

Join for free
XPH
XLV
Last sale
6/12/2026 at 3:47 PM
$60.62
$153.98
Previous close
06/11/2026
$59.77
$154.09
Consolidated volume
06/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of May 29, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XPH
XLV
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 6/12/2026 at 3:47 PM
Live
Closed
XPH
XLV
Last price
$60.62
$153.98
1D performance
+1.42%
-0.07%
AuM$362.12 M$39.34 B
E/R0.35%0.08%
Characteristics
XPH
XLV
Management strategyPassivePassive
ProviderState Street Investment ManagementState Street Investment Management
BenchmarkS&P Pharmaceuticals Select Industry IndexS&P Health Care Select Sector Index
N° of holdings4855
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 19, 2006December 16, 1998
ESGNoNo
Advertisement
Exposure

Countries

XPH
USA
89.49%
Other
10.51%
XLV
USA
97.39%
Other
2.61%

Sectors

XPH
Health Care
82.05%
Other
17.95%
XLV
Health Care
98.41%
Other
1.59%
Advertisement

Diversification

XPH

Total weight of top 15 holdings out of 15

33.31%
XLV

Total weight of top 15 holdings out of 15

70.92%

Top 15 holdings

Data as of April 30, 2026
XPH
ORGANON & CO
3.72%
CORCEPT THERAPEUTICS
2.48%
US29337E1029
2.41%
AXSOME THERA CMN STK
2.34%
OMEROS
2.20%
PERRIGO CO PLC
2.17%
US6402683063
2.08%
TREVI THERAPEUTICS
2.07%
TERNS PHARMACEUTICALS
2.03%
US45579U1097
2.01%
PACIRA BIOSCIENCES INC
2.00%
HARROW HEALTH
1.97%
JAZZ PHARMACEUTICALS
1.97%
HARMONY BIOSCIENCES HLDG
1.95%
ROYALTY PHARMA
1.93%
XLV
LILLY
14.09%
JOHNSON&JOHNSON
10.54%
ABBVIE
7.10%
UNITEDHEALTH GRP
6.38%
MERCK & CO INC
5.15%
AMGEN-T
3.55%
THERMO FISHER SCIENTIFIC
3.42%
INTUITIVE SURGICAL
3.09%
GILEAD SCIENCES
3.09%
ABBOTT LABS
3.00%
PFIZER
2.89%
BRISTOL-MYERS SQUIBB
2.35%
DANAHER
2.14%
VERTEX PHARMACEUTICALS
2.06%
STRYKER
2.06%
Frequently asked questions about XPH and XLV

How have the XPH and XLV ETFs performed in 2026?

As of June 11, 2026, XPH is up 6.83% year-to-date (YTD), while XLV has lost -0.05%. That puts XPH better performer ahead so far this year.

Which ETF is attracting more investor money: XPH or XLV?

Year-to-date, the XPH ETF saw +$110M in flows, compared to -$91M for XLV.

Which ETF is more volatile: XPH or XLV?

Over the past year, XPH had a volatility of 21.47%, while XLV experienced 15.02%.

Which ETF is bigger: XPH or XLV?

As of June 11, 2026, XPH holds $362.12 M in assets under management (AUM), while XLV manages $39.34 B.

What sectors do the XPH and XLV ETFs invest in?

XPH leans toward sectors like Health Care. Meanwhile, XLV focuses on Health Care.

What are the top holdings of the XPH ETF and XLV ETF?

XPH top holdings include ORGANON & CO, CORCEPT THERAPEUTICS and US29337E1029. XLV holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.

Which ETF is more diversified: XPH or XLV?

XPH holds 58 securities with 33.31% of its assets in the top 15. XLV has 58 securities and a top 15 weight of 70.92%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder